Sigma Planning Corp’s Chembio diagnostics, Inc. CEMI Stock Holding History

Sigma Planning Corp’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19,300	Closed	-$48K	–	1513
2021 Q3	$48K	Buy	19,300 +1,500	+8%	+$4.16K	﹤0.01%	1349
2021 Q2	$53K	Sell	17,800 -4,000	-18%	-$13.9K	﹤0.01%	1397
2021 Q1	$77K	Buy	21,800 +400	+2%	+$2.23K	﹤0.01%	1296
2020 Q4	$102K	Buy	+21,400	New	+$111K	﹤0.01%	1157

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EGM

Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Sigma Planning Corp's CEMI Position: Q4 2021 in Review

Sigma Planning Corp sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2021, closing a stake of 19,300 shares — an estimated $48K sold.

Sigma Planning Corp first reported a position in CEMI in Q4 2020 and held it in 4 quarters. The position peaked at $102K in Q4 2020. 43 funds tracked by Wall St. Rank hold CEMI as of Q4 2021.

Sigma Planning Corp reported no remaining Chembio diagnostics, Inc. position as of Q4 2021 after selling out during the quarter.
Sigma Planning Corp sold 19,300 Chembio diagnostics, Inc. shares in Q4 2021, an estimated $48K.
Sigma Planning Corp first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 4 quarters.
Sigma Planning Corp's Chembio diagnostics, Inc. position peaked at $102K in Q4 2020.
43 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2021.

Based on Sigma Planning Corp's 13F filing for Q4 2021, filed 2 Feb 2022.